| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE:ARDT) with a Outperform and lowers the price target from $21 t...
Truist Securities analyst David Macdonald maintains Ardent Health (NYSE:ARDT) with a Buy and lowers the price target from $2...
Stephens & Co. analyst Scott Fidel maintains Ardent Health (NYSE:ARDT) with a Overweight and lowers the price target fr...
Morgan Stanley analyst Craig Hettenbach downgrades Ardent Health (NYSE:ARDT) from Overweight to Equal-Weight and lowers the ...
B of A Securities analyst Kevin Fischbeck maintains Ardent Health (NYSE:ARDT) with a Underperform and lowers the price targe...